SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
🔥 科研通第二届『
应助活动周
』正在进行中,3月24-30日求助秒级响应🚀,千元现金等你拿。
当前排名🏆
📚 中科院2025期刊分区📊 已更新
带着太阳去旅行
Lv1
70 积分
2024-10-11 加入
感谢帮我找文献的各位大佬
最近求助
最近应助
互助留言
The role of neuropilin in bone/cartilage diseases
7天前
已完结
Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype
23天前
已完结
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024
1个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
1个月前
已完结
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
1个月前
已完结
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non–Small-Cell Lung Cancer
2个月前
已完结
Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review
2个月前
已完结
Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
2个月前
已完结
Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis
3个月前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了,么么哒
7天前
感谢,点赞,速度真快,帮大忙了,么么哒
22天前
感谢,点赞,速度真快
1个月前
感谢,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
2个月前
感谢,点赞,速度真快,帮大忙了,么么哒
2个月前
感谢,点赞,速度真快,帮大忙了,么么哒
2个月前
感谢,点赞,速度真快,帮大忙了
3个月前
感谢,点赞,速度真快,帮大忙了,么么哒
3个月前
感谢,速度真快,速度真快,点赞,帮大忙了,么么哒
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论